Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001.

Zhan C, Arispe IE, Kelley E, et al. Ambulatory Care Visits for Treating Adverse Drug Effects in the United States, 1995–2001. The Joint Commission Journal on Quality and Patient Safety. 2016;31(7). doi:10.1016/s1553-7250(05)31050-6.

Save
Print
January 2, 2017
Zhan C, Arispe IE, Kelley E, et al. The Joint Commission Journal on Quality and Patient Safety. 2016;31(7).
View more articles from the same authors.

This AHRQ–funded study estimates the national prevalence of adverse drug events by capturing data from outpatient physician visits. Using survey data, investigators report on more than 4 million office visits associated with a diagnostic code for an adverse drug event. Although upward trends over time were not statistically significant, the authors conclude that their findings and methods may offer a mechanism for continued tracking of this important safety concern on a national level.

Save
Print
Cite
Citation

Zhan C, Arispe IE, Kelley E, et al. Ambulatory Care Visits for Treating Adverse Drug Effects in the United States, 1995–2001. The Joint Commission Journal on Quality and Patient Safety. 2016;31(7). doi:10.1016/s1553-7250(05)31050-6.